OMGA
Income statement / Annual
Last year (2023), Omega Therapeutics, Inc.'s total revenue was $3.09 M,
an increase of 49.25% from the previous year.
In 2023, Omega Therapeutics, Inc.'s net income was -$97.43 M.
See Omega Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$3.09 M |
$2.07 M |
$144.00 K |
$0.00 |
$0.00 |
| Cost of Revenue |
$65.87 M
|
$5.19 M
|
$1.39 M
|
$1.15 M
|
$794.00 K
|
| Gross Profit |
-$62.78 M
|
-$3.12 M
|
-$1.24 M
|
-$1.15 M
|
-$794.00 K
|
| Gross Profit Ratio |
-20.29
|
-1.5
|
-8.63
|
0
|
0
|
| Research and Development Expenses |
$77.17 M
|
$80.00 M
|
$47.87 M
|
$21.06 M
|
$11.93 M
|
| General & Administrative Expenses |
$26.19 M
|
$21.82 M
|
$16.60 M
|
$6.24 M
|
$4.23 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$26.19 M
|
$21.82 M
|
$16.60 M
|
$6.24 M
|
$4.23 M
|
| Other Expenses |
$0.00
|
$3.02 M
|
$1.71 M
|
$1.35 M
|
$1.18 M
|
| Operating Expenses |
$103.36 M
|
$104.84 M
|
$66.18 M
|
$28.65 M
|
$17.34 M
|
| Cost And Expenses |
$103.36 M
|
$104.84 M
|
$66.18 M
|
$28.65 M
|
$17.34 M
|
| Interest Income |
$2.81 M
|
$222.00 K
|
$0.00
|
$777.00 K
|
$595.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$910.00 K
|
$777.00 K
|
$595.00 K
|
| Depreciation & Amortization |
$6.77 M
|
$5.19 M
|
$1.39 M
|
$1.15 M
|
$794.00 K
|
| EBITDA |
-$93.49 M |
-$97.58 M |
-$64.65 M |
-$27.50 M |
-$16.55 M |
| EBITDA Ratio |
-30.22
|
-47.07
|
-448.92
|
0
|
0
|
| Operating Income Ratio |
-32.4
|
-49.57
|
-458.56
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.83 M
|
$65.00 K
|
-$2.25 M
|
-$802.00 K
|
-$606.00 K
|
| Income Before Tax |
-$97.43 M
|
-$102.70 M
|
-$68.28 M
|
-$29.45 M
|
-$17.95 M
|
| Income Before Tax Ratio |
-31.49
|
-49.54
|
-474.17
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$97.43 M
|
-$102.64 M
|
-$69.16 M
|
-$30.20 M
|
-$18.53 M
|
| Net Income Ratio |
-31.49
|
-49.51
|
-480.29
|
0
|
0
|
| EPS |
-1.8 |
-2.14 |
-1.45 |
-0.63 |
-0.39 |
| EPS Diluted |
-1.8 |
-2.14 |
-1.45 |
-0.63 |
-0.39 |
| Weighted Average Shares Out |
$54.01 M
|
$47.88 M
|
$47.79 M
|
$47.84 M
|
$47.84 M
|
| Weighted Average Shares Out Diluted |
$54.01 M
|
$47.88 M
|
$47.79 M
|
$47.84 M
|
$47.84 M
|
| Link |
|
|
|
|
|
